Copyright Reports & Markets. All rights reserved.

Global Nuclear Medicine & Radiopharmaceuticals Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Nuclear Medicine & Radiopharmaceuticals

      • 1.1 Definition of Nuclear Medicine & Radiopharmaceuticals
      • 1.2 Nuclear Medicine & Radiopharmaceuticals Segment by Type
        • 1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Diagnostic Radioisotopes
        • 1.2.3 Therapeutic Radioisotopes
      • 1.3 Nuclear Medicine & Radiopharmaceuticals Segment by Applications
        • 1.3.1 Global Nuclear Medicine & Radiopharmaceuticals Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Oncology
        • 1.3.3 Cardiology
        • 1.3.4 Other
      • 1.4 Global Nuclear Medicine & Radiopharmaceuticals Overall Market
        • 1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue (2014-2025)
        • 1.4.2 Global Nuclear Medicine & Radiopharmaceuticals Production (2014-2025)
        • 1.4.3 North America Nuclear Medicine & Radiopharmaceuticals Status and Prospect (2014-2025)
        • 1.4.4 Europe Nuclear Medicine & Radiopharmaceuticals Status and Prospect (2014-2025)
        • 1.4.5 China Nuclear Medicine & Radiopharmaceuticals Status and Prospect (2014-2025)
        • 1.4.6 Japan Nuclear Medicine & Radiopharmaceuticals Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Status and Prospect (2014-2025)
        • 1.4.8 India Nuclear Medicine & Radiopharmaceuticals Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals
      • 2.3 Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
      • 2.4 Industry Chain Structure of Nuclear Medicine & Radiopharmaceuticals

      3 Development and Manufacturing Plants Analysis of Nuclear Medicine & Radiopharmaceuticals

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Nuclear Medicine & Radiopharmaceuticals Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Nuclear Medicine & Radiopharmaceuticals
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Nuclear Medicine & Radiopharmaceuticals Production and Capacity Analysis
      • 4.2 Nuclear Medicine & Radiopharmaceuticals Revenue Analysis
      • 4.3 Nuclear Medicine & Radiopharmaceuticals Price Analysis
      • 4.4 Market Concentration Degree

      5 Nuclear Medicine & Radiopharmaceuticals Regional Market Analysis

      • 5.1 Nuclear Medicine & Radiopharmaceuticals Production by Regions
        • 5.1.1 Global Nuclear Medicine & Radiopharmaceuticals Production by Regions
        • 5.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Regions
      • 5.2 Nuclear Medicine & Radiopharmaceuticals Consumption by Regions
      • 5.3 North America Nuclear Medicine & Radiopharmaceuticals Market Analysis
        • 5.3.1 North America Nuclear Medicine & Radiopharmaceuticals Production
        • 5.3.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Nuclear Medicine & Radiopharmaceuticals Import and Export
      • 5.4 Europe Nuclear Medicine & Radiopharmaceuticals Market Analysis
        • 5.4.1 Europe Nuclear Medicine & Radiopharmaceuticals Production
        • 5.4.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Nuclear Medicine & Radiopharmaceuticals Import and Export
      • 5.5 China Nuclear Medicine & Radiopharmaceuticals Market Analysis
        • 5.5.1 China Nuclear Medicine & Radiopharmaceuticals Production
        • 5.5.2 China Nuclear Medicine & Radiopharmaceuticals Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Nuclear Medicine & Radiopharmaceuticals Import and Export
      • 5.6 Japan Nuclear Medicine & Radiopharmaceuticals Market Analysis
        • 5.6.1 Japan Nuclear Medicine & Radiopharmaceuticals Production
        • 5.6.2 Japan Nuclear Medicine & Radiopharmaceuticals Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Nuclear Medicine & Radiopharmaceuticals Import and Export
      • 5.7 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Market Analysis
        • 5.7.1 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Production
        • 5.7.2 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Import and Export
      • 5.8 India Nuclear Medicine & Radiopharmaceuticals Market Analysis
        • 5.8.1 India Nuclear Medicine & Radiopharmaceuticals Production
        • 5.8.2 India Nuclear Medicine & Radiopharmaceuticals Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Nuclear Medicine & Radiopharmaceuticals Import and Export

      6 Nuclear Medicine & Radiopharmaceuticals Segment Market Analysis (by Type)

      • 6.1 Global Nuclear Medicine & Radiopharmaceuticals Production by Type
      • 6.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type
      • 6.3 Nuclear Medicine & Radiopharmaceuticals Price by Type

      7 Nuclear Medicine & Radiopharmaceuticals Segment Market Analysis (by Application)

      • 7.1 Global Nuclear Medicine & Radiopharmaceuticals Consumption by Application
      • 7.2 Global Nuclear Medicine & Radiopharmaceuticals Consumption Market Share by Application (2014-2019)

      8 Nuclear Medicine & Radiopharmaceuticals Major Manufacturers Analysis

      • 8.1 Bracco Imaging
        • 8.1.1 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
        • 8.1.2 Bracco Imaging Product Introduction, Application and Specification
        • 8.1.3 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Bayer
        • 8.2.1 Bayer Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
        • 8.2.2 Bayer Product Introduction, Application and Specification
        • 8.2.3 Bayer Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Mallinckrodt
        • 8.3.1 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
        • 8.3.2 Mallinckrodt Product Introduction, Application and Specification
        • 8.3.3 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Nordion
        • 8.4.1 Nordion Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
        • 8.4.2 Nordion Product Introduction, Application and Specification
        • 8.4.3 Nordion Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Triad Isotopes
        • 8.5.1 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
        • 8.5.2 Triad Isotopes Product Introduction, Application and Specification
        • 8.5.3 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Lantheus
        • 8.6.1 Lantheus Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
        • 8.6.2 Lantheus Product Introduction, Application and Specification
        • 8.6.3 Lantheus Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 IBA Group
        • 8.7.1 IBA Group Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
        • 8.7.2 IBA Group Product Introduction, Application and Specification
        • 8.7.3 IBA Group Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 GE Healthcare
        • 8.8.1 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
        • 8.8.2 GE Healthcare Product Introduction, Application and Specification
        • 8.8.3 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 China Isotope & Radiation
        • 8.9.1 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
        • 8.9.2 China Isotope & Radiation Product Introduction, Application and Specification
        • 8.9.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Jubilant Pharma
        • 8.10.1 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served
        • 8.10.2 Jubilant Pharma Product Introduction, Application and Specification
        • 8.10.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Eli Lilly
      • 8.12 Advanced Accelerator Applications
      • 8.13 SIEMENS
      • 8.14 Dongcheng
      • 8.15 Navidea

      9 Development Trend of Analysis of Nuclear Medicine & Radiopharmaceuticals Market

      • 9.1 Global Nuclear Medicine & Radiopharmaceuticals Market Trend Analysis
        • 9.1.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Nuclear Medicine & Radiopharmaceuticals Regional Market Trend
        • 9.2.1 North America Nuclear Medicine & Radiopharmaceuticals Forecast 2019-2025
        • 9.2.2 Europe Nuclear Medicine & Radiopharmaceuticals Forecast 2019-2025
        • 9.2.3 China Nuclear Medicine & Radiopharmaceuticals Forecast 2019-2025
        • 9.2.4 Japan Nuclear Medicine & Radiopharmaceuticals Forecast 2019-2025
        • 9.2.5 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Forecast 2019-2025
        • 9.2.6 India Nuclear Medicine & Radiopharmaceuticals Forecast 2019-2025
      • 9.3 Nuclear Medicine & Radiopharmaceuticals Market Trend (Product Type)
      • 9.4 Nuclear Medicine & Radiopharmaceuticals Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Nuclear Medicine & Radiopharmaceuticals Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Nuclear Medicine & Radiopharmaceuticals market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Nuclear Medicine & Radiopharmaceuticals volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nuclear Medicine & Radiopharmaceuticals market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Nuclear Medicine & Radiopharmaceuticals in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Nuclear Medicine & Radiopharmaceuticals manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Bracco Imaging
        Bayer
        Mallinckrodt
        Nordion
        Triad Isotopes
        Lantheus
        IBA Group
        GE Healthcare
        China Isotope & Radiation
        Jubilant Pharma
        Eli Lilly
        Advanced Accelerator Applications
        SIEMENS
        Dongcheng
        Navidea

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Diagnostic Radioisotopes
        Therapeutic Radioisotopes

        Segment by Application
        Oncology
        Cardiology
        Other

        Buy now